MedPath

Jochen Vehoff

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS

Phase 4
Completed
Conditions
Multiple Sclerosis
Autonomic Nervous System Dysfunction
Interventions
First Posted Date
2014-01-29
Last Posted Date
2016-04-29
Lead Sponsor
Jochen Vehoff
Target Recruit Count
33
Registration Number
NCT02048072
Locations
🇨🇭

Cantonal Hospital St. Gallen, St. Gallen, SG, Switzerland

© Copyright 2025. All Rights Reserved by MedPath